Shop

COVAL-H is a combination medication containing Valsartan and Hydrochlorothiazide, produced by Viralian Company. It belongs to the class of antihypertensive combinations and is used for the effective control of blood pressure in patients who do not achieve adequate response with monotherapy.

Valsartan is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, leading to vasodilation. Hydrochlorothiazide is a thiazide diuretic that reduces blood pressure by increasing the excretion of water and salt through the kidneys. The combination of these two agents in COVAL-H results in a synergistic effect for more effective blood pressure reduction.

COVAL-H is prescribed for the treatment of primary hypertension and to help reduce the risk of stroke, heart attack, and other cardiovascular complications. The tablets are typically taken once daily, and dosage should be adjusted based on the patient’s clinical condition and response to treatment.

Contraindications include hypersensitivity to Valsartan, Hydrochlorothiazide, or any other thiazide derivatives, pregnancy (especially during the second and third trimesters), severe renal or hepatic impairment, and severe electrolyte imbalances.

Common side effects may include dizziness, headache, increased urination, and mild fatigue.
COVAL-H is a high-quality product by Viralian, offering effective and sustained blood pressure control.